Georgeio Semaan , Abdullah Bilal Öztürk , Gopalakrishnan Kumar
{"title":"Comparative techno-economic assessment of multi-feedstock to multi-product integrated lignocellulosic biorefinery","authors":"Georgeio Semaan , Abdullah Bilal Öztürk , Gopalakrishnan Kumar","doi":"10.1016/j.bej.2025.109892","DOIUrl":null,"url":null,"abstract":"<div><div>A techno‑economic assessment was performed for a multi‑feedstock lignocellulosic biorefinery that converts Norwegian tomato and cucumber crop residues, spent coffee grounds, and brewers’ spent grain into value‑added chemicals. Scenario 1 integrates dilute oxalic‑acid hydrolysis (DAH) with oxalic‑acid‑assisted ethanol‑organosolv delignification (ORG) and co‑produces ethanol, lactic acid, ethanol‑organosolv lignin, furfural, 5‑hydroxymethylfurfural, and electricity. Scenario 2 omits the lactic‑acid train, whereas Scenario 3 employs DAH, only without the ORG or lactic acid sections. Mass and energy balance simulations informed discounted cash flow models for feedstock capacities of 25 and 250 kt/yr. At 25 kt/yr, all scenarios were unprofitable. Scaling to 250 kt/yr improved outcomes for Scenarios 1 and 3, yielding 11.5–12.6 % internal rate of return (IRR), US$ 183.7–185MM net present value (NPV). ORG inclusion reduced overall returns due to elevated capital and operating costs. Integrated operation produced negative net unit production costs, indicating internal cost cross-subsidization among co-products. Sensitivity analysis identified revenue and operating expenditures as primary determinants of NPV and IRR. Monte Carlo analysis estimated a 93.7 % probability of profitability in all simulated outcomes. The findings underscore the importance of scaling up and diversifying product portfolio in future biorefinery deployments.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"224 ","pages":"Article 109892"},"PeriodicalIF":3.7000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25002669","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
A techno‑economic assessment was performed for a multi‑feedstock lignocellulosic biorefinery that converts Norwegian tomato and cucumber crop residues, spent coffee grounds, and brewers’ spent grain into value‑added chemicals. Scenario 1 integrates dilute oxalic‑acid hydrolysis (DAH) with oxalic‑acid‑assisted ethanol‑organosolv delignification (ORG) and co‑produces ethanol, lactic acid, ethanol‑organosolv lignin, furfural, 5‑hydroxymethylfurfural, and electricity. Scenario 2 omits the lactic‑acid train, whereas Scenario 3 employs DAH, only without the ORG or lactic acid sections. Mass and energy balance simulations informed discounted cash flow models for feedstock capacities of 25 and 250 kt/yr. At 25 kt/yr, all scenarios were unprofitable. Scaling to 250 kt/yr improved outcomes for Scenarios 1 and 3, yielding 11.5–12.6 % internal rate of return (IRR), US$ 183.7–185MM net present value (NPV). ORG inclusion reduced overall returns due to elevated capital and operating costs. Integrated operation produced negative net unit production costs, indicating internal cost cross-subsidization among co-products. Sensitivity analysis identified revenue and operating expenditures as primary determinants of NPV and IRR. Monte Carlo analysis estimated a 93.7 % probability of profitability in all simulated outcomes. The findings underscore the importance of scaling up and diversifying product portfolio in future biorefinery deployments.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.